U.S. Markets closed
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • Dow 30

    34,584.88
    -166.44 (-0.48%)
     
  • Nasdaq

    15,043.97
    -137.96 (-0.91%)
     
  • Russell 2000

    2,236.87
    +3.96 (+0.18%)
     
  • Crude Oil

    71.96
    -0.65 (-0.90%)
     
  • Gold

    1,753.90
    -2.80 (-0.16%)
     
  • Silver

    22.42
    -0.33 (-1.44%)
     
  • EUR/USD

    1.1732
    -0.0040 (-0.3402%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • Vix

    20.81
    +2.12 (+11.34%)
     
  • GBP/USD

    1.3737
    -0.0059 (-0.4286%)
     
  • USD/JPY

    109.8950
    +0.1770 (+0.1613%)
     
  • BTC-USD

    48,620.28
    +651.79 (+1.36%)
     
  • CMC Crypto 200

    1,193.48
    -32.05 (-2.62%)
     
  • FTSE 100

    6,963.64
    -63.84 (-0.91%)
     
  • Nikkei 225

    30,500.05
    +176.71 (+0.58%)
     

IDEAYA (IDYA) Looks Good: Stock Adds 10.2% in Session

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

IDEAYA Biosciences, Inc. IDYA was a big mover last session, as the company saw its shares rises more than 10% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This stock which remained volatile and traded within the range of $6.99-$10.23 in the past one-month time frame, witnessed a sharp increase yesterday.

The move came after the company selected development candidate IDE397 for its Methionine adenosyltransferase 2a (MAT2A) Synthetic Lethality program.

The company has seen three negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

IDEAYA currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

IDEAYA Biosciences, Inc. Price

IDEAYA Biosciences, Inc. Price
IDEAYA Biosciences, Inc. Price

IDEAYA Biosciences, Inc. price | IDEAYA Biosciences, Inc. Quote

A better-ranked stock in the Medical - Biomedical and Genetics industry is Aytu Bioscience, Inc. AYTU, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Aytu Bioscience, Inc. (AYTU) : Free Stock Analysis Report
 
IDEAYA Biosciences, Inc. (IDYA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.